| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.33 | 0.01 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |